Form 4: ANI Pharmaceuticals Executive Meredith Cook Sells 250 Shares
SEC Form 4
Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 250 shares of common stock on May 13, 2024, at a price of $67.69 per share.
Summary
- On May 13, 2024, Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 250 shares of common stock.
- The transaction was executed at a price of $67.69 per share.
- Following the transaction, Meredith Cook directly owns 59,481 shares of ANI Pharmaceuticals.
- The sale was conducted under a Rule 10b5-1 trading plan adopted on August 11, 2023.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of an insider sale under a pre-existing trading plan.
Industry Context
This is a routine disclosure of an insider stock sale. Insider transactions are common and are closely watched by investors for signals about a company's prospects. A sale doesn't necessarily indicate a negative outlook, especially when executed under a pre-arranged trading plan.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the small number of shares sold.
Key Dates
| Date | Description |
|---|---|
| 08/11/2023 | Date of adoption of Rule 10b5-1 trading plan |
| 05/13/2024 | Date of stock sale transaction |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.